BIO-UV Group S.A. (ALTUV.PA)
Lunel, FR
Based in Lunel, France, BIO-UV Group S.A. specializes in the conception, production, and commercialization of ultraviolet (UV) light systems for the purification of water and disinfection of surfaces. Serving both private individuals and professionals, the company, established in 2000, provides a wide array of solutions. For swimming pools and spas, their offerings include advanced disinfection systems like O'Clear UV and DELTA-UV, along with BIO-UV INOX for chlorine-free treatment. They also offer automated pool management tools such as BIO-UV COMBIPOOL for chemical injection and pH regulation, BIO-UV REGUL pH for pH maintenance, and BIO-UV TEMPO to manage daily disinfectant dosing based on water temperature. Larger commercial and semi-commercial pools can utilize their MP Touch Screen and MPL Super Deluxe systems for enhanced disinfection and dechloramination. Beyond recreational water, BIO-UV Group delivers DW systems for producing drinking water, and RW for the tertiary treatment and disinfection of municipal or industrial wastewater. Industrial processes benefit from IAM and IBP+ solutions for water treatment. In the marine sector, BIO-SEA B and BIO-SEA EASY-TO-FIT manage ballast water on ships. Specialized applications also include BIO-SUN for water disinfection in remote areas and UV HOME for domestic pure water supply. Their portfolio further encompasses HDPE HO/AM for treating corrosive or saline water, and UV and UV HO units specifically designed for freshwater applications in aquaculture, fish farming (pisciculture), aquariums, ornamental ponds, and biological pools. Additionally, BIO-UV Group provides the BIO-SCAN LIGHT system for surface disinfection, catering to a variety of sectors such as healthcare, maritime, hospitality (cafes, hotels, restaurants), retail, and transport.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -2.10% | +2.94% | +7.69% | -11.95% | -5.41% | -33.01% | -64.56% | -75.35% | -63.73% | -63.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Waste Management: +4.3%-9.3% Q4'25: -18.1% (vs Q4'23)
-
EPS growth Waste Management: +10.8%+1,863.3% ★ Q4'25: +64.5% (vs Q4'23)
-
FCF margin FCF growth · Waste Management: +46.5%+0.4% Q4'25: +13.0% (vs Q4'23)
-
EBIT margin Waste Management: +13.2%-3.3% Q4'25: -21.1% (vs Q4'23)
-
ROIC Waste Management: +6.2%-2.2% Q4'25: -16.7% (vs Q4'23)
-
Share dilution Waste Management: +0.0%+36.7% Q4'25: +30.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Waste Management: 1.12×12.64× Q4'25: -2.95× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
12.42M
est: 12.59M (-1.4%)
|
19.98M
est: 19.79M (+0.9%)
|
32.17M
est: 32.07M (+0.3%)
|
33.46M
est: 33.50M (-0.1%)
|
51.29M
est: 51.40M (-0.2%)
|
43.13M
est: 43.10M (+0.1%)
|
39.58M
est: 43.10M (-8.2%)
|
35.90M
est: 35.90M (+0.0%)
|
38.50M
38.50M – 38.50M
+7.2% YoY
|
40.80M
40.80M – 40.80M
+6.0% YoY
|
| EBITDA |
861.8K
est: 1.22M (-29.5%)
|
1.35M
est: 611.7K (+120.1%)
|
1.71M
est: 1.10M (+55.5%)
|
3.35M
est: 1.33M (+151.4%)
|
6.38M
est: 1.43M (+346.4%)
|
4.43M
est: 1.65M (+168.8%)
|
4.18M
est: 4.11M (+1.6%)
|
1.60M
est: 3.43M (-53.3%)
|
3.67M
3.67M – 3.67M
+7.2% YoY
|
3.89M
3.89M – 3.89M
+6.0% YoY
|
| EBIT |
-24.2K
est: 480.0K (-105.0%)
|
-349.8K
est: 133.4K (-362.2%)
|
1.40M
est: -967.1K (+244.7%)
|
997.6K
est: -1.17M (+185.2%)
|
3.67M
est: -1.26M (+392.5%)
|
1.03M
est: -1.45M (+171.2%)
|
867.8K
est: 980.6K (-11.5%)
|
-1.20M
est: 816.8K (-246.9%)
|
876.0K
876.0K – 876.0K
+7.2% YoY
|
928.3K
928.3K – 928.3K
+6.0% YoY
|
| Net Income |
46.3K
est: 160.0K (-71.1%)
|
-448.1K
est: 74.5K (-701.1%)
|
583.9K
est: -776.7K (+175.2%)
|
689.4K
est: -940.0K (+173.3%)
|
2.42M
est: 2.42M (+0.0%)
|
124.9K
est: 128.0K (-2.4%)
|
31.4K
est: 1.41M (-97.8%)
|
836.3K
est: 708.0K (+18.1%)
|
1.27M
1.27M – 1.27M
+80.0% YoY
|
1.56M
1.56M – 1.56M
+22.2% YoY
|
| SGA |
3.7K
est: 1.58M (-99.8%)
|
49.4K
est: 6.41M (-99.2%)
|
6.67M
est: 9.18M (-27.3%)
|
596.0K
est: 11.11M (-94.6%)
|
9.38M
est: 11.91M (-21.2%)
|
9.44M
est: 13.74M (-31.3%)
|
—
est: 3.62M (-100.0%)
|
—
est: 3.01M (-100.0%)
|
3.23M
3.23M – 3.23M
+7.2% YoY
|
3.42M
3.42M – 3.42M
+6.0% YoY
|
| EPS |
0.01
est: 0.02 (-61.2%)
|
-0.03
est: -0.01 (-209.3%)
|
0.07
est: 0.12 (-43.1%)
|
0.07
est: 0.15 (-53.7%)
|
0.24
est: 0.37 (-35.1%)
|
0.01
est: 0.17 (-92.8%)
|
0.00
est: 0.10 (-97.0%)
|
0.06
est: 0.05 (+17.8%)
|
0.09
0.09 – 0.09
+80.0% YoY
|
0.11
0.11 – 0.11
+22.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gilles Wallez | Director of Operations | — | — |
| Laurent-Emmanuel Migeon | Chairman & Chief Executive Officer | — | male |
| Sebastien Marin-Lafleche | Director of Finance | — | male |
| Simon Marshall | Director of Sales & Marketing and Director | — | male |
| Xavier Bayle | R&D Director and Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALTUV.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
